2005
DOI: 10.1111/j.1399-3038.2005.00273.x
|View full text |Cite
|
Sign up to set email alerts
|

Discrepant clinical responses and blood chemokine profiles between two non‐steroidal anti‐inflammatory medications for children with mild persistent asthma

Abstract: In a randomized study, two oral medications, ketotifen and montelukast, were compared for children with mild persistent asthma. Montelukast revealed faster clinical responses than ketotifen, showing improved exhaled nitric oxide, peak expiratory flow, and asthma scores in 1 wk. After 8-wk of medication, both ketotifen and montelukast revealed improved clinical responses. However, 8 wk of ketotifen, but not montelukast, decreased plasma serum thymus and activation-regulated chemokine (317.854 +/- 207.906 vs. 18… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
16
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 16 publications
(23 reference statements)
1
16
0
Order By: Relevance
“…At present the mechanism through which CCL17 induced NOS2 is not evident but these findings are in agreement with a previous clinical study showing that therapeutic improvement in pediatric asthma was associated with decreased NO and CCL17. 50 The present study also demonstrated that CCL22 inhibited the expression of Arg1 in WT but not CCR4 Ϫ/Ϫ macrophages. The inhibitory effect of CCL22 on Arg1 expression is not readily explained by previously published observations.…”
Section: Discussionsupporting
confidence: 57%
“…At present the mechanism through which CCL17 induced NOS2 is not evident but these findings are in agreement with a previous clinical study showing that therapeutic improvement in pediatric asthma was associated with decreased NO and CCL17. 50 The present study also demonstrated that CCL22 inhibited the expression of Arg1 in WT but not CCR4 Ϫ/Ϫ macrophages. The inhibitory effect of CCL22 on Arg1 expression is not readily explained by previously published observations.…”
Section: Discussionsupporting
confidence: 57%
“…Polyinosinic:polycytidylic acids [poly(I:C)] is a synthetic mimetic of dsRNA and functions through an endosomal receptor, such as Tolllike receptor 3, or cytosolic receptors and can activate innate immunity [22]. MDCs play a role not only in asthma but also in allergic rhinitis [8,24]. MDCs were increased in the exhaled breath condensate and plasma in children with asthma [25].…”
Section: Discussionmentioning
confidence: 98%
“…LPS can induce the Th1-related chemokine (IP-10) and the Th2-related chemokine (MDC) production in human monocytes [10]. In addition, the Th1-and Th2-related chemokines play an important role in human allergic asthma [8,9,20]. Several anti-allergic or anti-asthmatic medications, such as mast cell stabilizers and leukotriene receptor antagonists, have some effects on chemokine expression or chemokine-induced chemotaxis [10,21].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Macrophage-derived chemokine (MDC; CCL22) and thymus-and activation-regulated chemokine (TARC; CCL17) are Th2 chemokines involved in the recruitment of CC chemokine receptor 4-bearing Th2 cells in allergen-induced inflammation [7]. Increased levels of plasma MDC and TARC have been found in children with acute asthma, but their levels decrease after ketotifen treatment [8].…”
mentioning
confidence: 99%